Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 4, 1997, Pages 451-456

  Li, Q ^a   Feenstra, M ^a   Pfaffendorf, M ^a   Eijsman, L ^a   Van Zwieten, P A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aminopeptidase inhibitor; Angiotensin; Angiotensin antagonist; Cyclooxygenase inhibitor; Human saphenous vein; Tachyphylaxis

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; AMASTATIN; AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR ANTAGONIST; INDOMETACIN; LOSARTAN; METHACHOLINE; NORADRENALIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN; SAPHENOUS VEIN GRAFT; TACHYPHYLAXIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

AGED; AGED, 80 AND OVER; AMINOPEPTIDASES; ANGIOTENSIN II; ANGIOTENSIN III; ANTI-BACTERIAL AGENTS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GLUTAMYL AMINOPEPTIDASE; HUMANS; IMIDAZOLES; LOSARTAN; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PEPTIDES; PROTEASE INHIBITORS; PYRIDINES; RECEPTORS, ANGIOTENSIN; SAPHENOUS VEIN; TACHYPHYLAXIS; TETRAZOLES; VASOCONSTRICTOR AGENTS;

EID: 0030993265     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199704000-00004     Document Type: Article

References (33)

1. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
2. Bernstein KE, Berk BC. The biology of angiotensin II receptors. Am J Kidney Dis 1993;22:745-54.
3. Nicholls MG, Charles CJ, Crozier IG, et al. Blockade of the reninangiotensin system. J Hypertens Suppl 1994;12:S95-103.
4. Zhang JS, van Meel JCA, Pfaffendorf M, van Zwieten PA. Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein. Naunyn-Schmiedeberg's Arch Pharmacol 1993;347:220-4.
5. Campbell DJ, Kladis A, Valentijn AJ. Effects of losartan on angiotensin and bradykinin peptides and angiotensin converting enzyme. J Cardiovasc Pharmacol 1995;26:233-40.
6. van Zwieten PA. Changing insights in the drug treatment of congestive heart failure. Exp Opin Invest Drugs 1995;4:1045-56.
7. Taylor KM, Bain WH, Russel M, Brannan JJ, Mortor IJ. Peripheral vascular resistance and angiotensin II levels during pulsatile cardiopulmonary bypass. Thorax 1979;34:594-8.
8. Cooper TJ, Clutton-Brock TH, Jones SN, Tinker J, Treasure T. Factors relating to the development of hypertension after cardiopulmonary bypass. Br Heart J 1985;54:91-5.
9. Barker JE, Anderson J, Treasure T, Piper PJ. Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin II. J Clin Pharmac 1994;38:57-62.
10. Li Q, Zhang J, Pfaffendorf M, van Zwieten PA. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br J Pharmacol 1995;116:2463-70.
11. Li Q, Zhang J, Pfaffendorf M, van Zwieten PA. Direct Chronotropic effects of angiotensin II and angiotensin III in pithed rats and isolated rat atria. Br J Pharmacol 1996;118:1653-8.
12. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 1991; 12:55-9.
13. Chiu AT, Herblin WF, Ardecky RJ, et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;165:196-203.
14. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin (I-VII), a member of circulating angiotensin peptides. Hypertension 1991;17:131-8.
15. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin (I-VII). Peptides 1993;14:679-84.
16. Nakamoto H, Ferrario CM, Fuller SB, Robaaczewski DL, Winicov E, Dean RH. Angiotensin (I-VII) and nitric oxide interaction in renovascular hypertension. Hypertension 1995;25:796-82.
17. Robertson MJ, Cunoosamy MP, Clark KL. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol 1992;106: 166-72.
18. 125I]angiotensin II binding in pig aorta. Eur J Pharmacol 1992;215:259-64.
19. Southard JH, van Gulik TM, Ametani MS, et al. Important components of the UW solution. Transplantation 1990;49:251-7.
20. Vischjager M, van Gulik TM, Pfaffendorf M, et al. Morphology and function of dog arterial grafts preserved in UW solution. Eur J Vasc Endovasc Surg 1995;10:431-9.
21. Hüsken BCP, Vroom MB, Timmenga EF, Pfaffendorf M, van Zwieten PA. Vasodilator effect of levcromakalim in isolated human small subcutaneous arteries. Eur J Pharmacol 1995;287:313-6.
22. Vroom MB, Pfaffendorf M, van Wezel HB, van Zwieten PA. Effect of phosphodiesterase inhibitors on human arteries in vitro. Br J Anaesth 1996;76:122-9.
23. Ahmad S, Ward PE. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 1990;252:643-9.
24. Wong PC, Hart SD, Zaspel AM, et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD 123177 (AII-2). J Pharmacol Exp Ther 1990;255:584-92.
25. Illiano S, Marsault R, Descombes J, Verbeuren T, Vanhoutte P. Regulation of nitric oxide-like activity by prostanoids in smooth muscles of the canine saphenous vein. Br J Pharmacol 1996;117: 360-4.
26. Zhang J, Pfaffendorf M, van Zwieten PA. Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam Clin Pharmacol 1995;9:25-9.
27. Oshiro ME, Paiva AC, Paiva TB. Endothelium-dependent inhibition of the use of extracellular calcium for the arterial response to vasoconstrictor agents. Gen Pharmacol 1985;16:567-72.
28. Svane D, Kahr O, Hansen VB, Holm-Nielsen P, Forman A. Angiotensin-converting enzyme activity and contractile effects of angiotensin I and angiotensin II in human uteroplacental arteries. Am J Obstet Gynecol 1995;172:991-7.
29. Andersson KE, Hedlund H, Stahl M. Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated smooth muscle from the human detrusor. Acta Physiol Scand 1992;145:253-9.
30. Sorokin G, Grant NM, Egan BM, Lombard JH. Cyclooxygenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries. Am J Obstet Gynecol 1992;167:110-4.
31. Oshiro MEM, Shimuta SI, Paiva TB, Paiva ACM. Evidence for a regulatory site in the angiotensin II receptor of smooth muscle. Eur J Pharmacol 1989;166:411-7.
32. Kanashiro CA, Paiva TB, Paiva ACM, Prioste RN, Aboulafia J, Shimuta SI. Angiotensin II tachyphylaxis in the guinea pig ileum and its prevention: a pharmacological and biochemical study. J Pharmacol Exp Ther 1995;275:1543-50.
33. Yang ZH, Arnet U, von Segesser L, Siebenmann R, Turina M, Lüscher TF. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. J Cardiovasc Pharmacol 1993; 22(Suppl. 5):S17-22.